Results 151 to 160 of about 12,590 (214)

Machine-Learning Prediction of Oral Drug-Induced Liver Injury (DILI) via Multiple Features and Endpoints. [PDF]

Biomed Res Int, 2020
Liu X, Zheng D, Zhong Y, Xia Z, Luo H, Weng Z.   +5 more
europepmc   +1 more source

Regular Consumption of Green Tea as an Element of Diet Therapy in Drug-Induced Liver Injury (DILI). [PDF]

Nutrients
Winiarska-Mieczan A, Jachimowicz-Rogowska K, Kwiecień M, Borsuk-Stanulewicz M, Tomczyk-Warunek A, Stamirowska-Krzaczek E, Purwin C, Stryjecka M, Tomaszewska M.   +8 more
europepmc   +1 more source

The evolution of strategies to minimise the risk of human drug-induced liver injury (DILI) in drug discovery and development. [PDF]

Arch Toxicol, 2020
Walker PA, Ryder S, Lavado A, Dilworth C, Riley RJ.   +4 more
europepmc   +1 more source

S2840 Drug-Induced Liver Injury (DILI) Secondary to Kratom Use

American Journal of Gastroenterology, 2021
Ali Wakil, Alsadiq Al-Hillan, Mujtaba Mohamed, Fayssa Salomon, Gopala Koneru   +4 more
openaire   +2 more sources

New classification of drug induced liver injury (DILI) in AASLD guidance: What is next? [PDF]

Hepatol Forum
Ercin CN.
europepmc   +1 more source

Exploring Individual Variability in Drug-Induced Liver Injury (DILI) Responses through Metabolomic Analysis. [PDF]

Int J Mol Sci
Moreno-Torres M, Quintás G, Martínez-Sena T, Jover R, Castell JV.   +4 more
europepmc   +1 more source

Drug-induced liver injury (DILI) ascribed to non-steroidal anti-inflammatory drugs (NSAIDs) in the USA-Update with genetic correlations. [PDF]

Liver Int
Bonkovsky HL, Ghabril M, Nicoletti P, Dellinger A, Fontana RJ, Barnhart H, Gu J, Daly AK, Aithal GP, Phillips EJ, Kleiner DE, US DILIN Investigators.   +11 more
europepmc   +1 more source

Delayed drug-induced liver injury (DILI) and flare of chronic plaque psoriasis secondary to lisinopril use. [PDF]

BMJ Case Rep
Jarman GL, Webb GJ.
europepmc   +1 more source

A case report of a drug-induced liver injury (DILI) caused by multiple antidepressants with causality established by the updated Roussel Uclaf causality assessment method (RUCAM) and in vitro testing. [PDF]

Clin Case Rep, 2020
González-Muñoz M, Monserrat Villatoro J, Marín-Serrano E, Stewart S, Bardón Rivera B, Marín J, Martínez de Soto L, Seco Meseguer E, Ramírez E.   +8 more
europepmc   +1 more source

A computational study to identify Sesamol derivatives as NRF2 activator for protection against drug-induced liver injury (DILI). [PDF]

Mol Divers
Mili A, Birangal S, Nandakumar K, Lobo R.   +3 more
europepmc   +1 more source